Product Reports Resources Pricing Login Book a demo

OncoMed Pharmaceuticals

Biotech & Life Sciences · Redwood City, United States · Founded 2004 · IPO 2013

Improving cancer treatment by creating novel medicines

Revenue $27M

Talent graph

OncoMed Pharmaceuticals's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on OncoMed Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage
Morgenthaler Ventures
U.S. Venture Partners
The Vertical Group
Latterell Venture Partners
Series B+ 6 investors entered at this stage
Delphi Ventures
Bay Partners
Adams Street Partners
DeNovo Ventures
Nomura Phase4 Ventures
Phase4 Partners

Global footprint

Where OncoMed Pharmaceuticals has talent and traffic

Workforce by country
🇺🇸 United States · Redwood City HQ
Book a demo for the full country breakdown
Web traffic by country
1.6K monthly visits
across markets
🇺🇸 United States100%
🇩🇪 Germany0%
Top 2 markets shown

Market sentiment

What the market is saying about OncoMed Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about OncoMed Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See OncoMed Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.